BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal Medicine

  Abstract discussing Talicia pharmacokinetics and exposure-response presented as ePoster at Digestive Disease Week® (DDW) 2020

  May 5, 2020

   · 

  14 min read
• XENLETA® (Lefamulin) Treatment Results in a Rapid Time-to-Clinical Response in Hospitalized Patients with Community-Acquired Bacterial Pneumonia (CABP)

  Results support Xenleta as an empiric, short-course monotherapy replacement for respiratory fluoroquinolones for treatment of CABP

  May 5, 2020

   · 

  11 min read
• BioMidwest

  Zimmer Biomet Holdings to Present at the UBS 2020 Virtual Global Healthcare Conference

  Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that Executive Vice President and Chief Financial Officer Suky Upadhyay will be participating in a fireside chat at the UBS 2020 Virtual Global Healthcare Conference on Tuesday, May 19, at 1:20 p.m. Eastern Time..

  May 5, 2020

   · 

  1 min read
• Deals

  Evogene Publishes Letter to Shareholders - May 5, 2020

  Evogene Ltd., a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, by utilizing cutting edge computational biology technologies, announces a letter to the shareholders from President and CEO, Ofer Haviv.

  May 5, 2020

   · 

  11 min read